Navigation Links
New Research Triangle Company Provides Innovative Global Services To The Pharmaceutical Industry

RALEIGH, N.C., Sept. 26, 2013 /PRNewswire/ -- The Research Triangle is no stranger to the pharmaceutical industry, but newcomer Clintrax Global, Inc. is changing how the industry thinks about clinical trial contract negotiations.

Clintrax Global opened for business in January 2013, with a mission to improve the way clinical trial contracts and budgets are negotiated. The company specializes as a functional service provider for pharmaceutical/biotechnology companies and contract research organizations (CROs) during the process of drug development. Clintrax provides these clients with worldwide contract and budget negotiation services with clinical trial sites including small clinics, large hospitals, and multicenter academic institutions.

Clintrax Global's unique business model is based on a seamless, centrally managed global footprint of in-country legal negotiators, which allows the company to execute agreements in over 60 countries in their local languages, and in accordance with each country's specific legal, regulatory and customary requirements.  The company focuses on shortening negotiation times in order to minimize costly delays in the conduct of clinical trials.  The sooner contracts are negotiated, the sooner the site can begin trial enrollment and provide knowledge about the drug.

Clintrax Global also offers a unique cloud-based tracking and reporting system, which allows clients to monitor and track the contract negotiation process in real time. This transparency gives clients the ability to ascertain the status of any individual contract throughout its life cycle.

Though the company is new, it brings together a team with years of experience, expertise, and success in clinical contracts. "Our personnel's breadth of local legal and budget negotiation experience in clinical trials allows us the flexibility to adapt to each client's needs on a global basis in order to quickly negotiate contracts while maintaining a high level of quality," says Clintrax Global Vice President of Operations, Elizabeth Easley. Clintrax Global endeavors to transform the contract negotiation service model in the clinical trial industry and looks forward to growth as the world's leading functional service provider for clinical trial contract negotiations.

Call Colin Dietch, (919) 322-2398 for more information.

SOURCE Clintrax Global
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lack of Formulary Access Tops List of Limitations Primary Care Physicians Face With e-Prescribing Systems, Says New Research Report from SciMedica Group MR&C
2. Indivumed Sells Inostics, the plasma-DNA Company, to Sysmex and Expands its Clinical Research Service and Patient Diagnostics Business
3. inVentiv Health Clinical Launches Physician Network For Late-Stage Research
4. Aethlon Medical Announces the Appointment of Dr. Cicek Gercel-Taylor as Clinical Research Director of Exosome Sciences, Inc.
5. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
6. Research-based Pharmaceutical Industry Calls for Public-Private Sector Engagement to Accelerate Progress Towards the Millennium Development Goals (MDGs) and in Planning New Development Agenda
7. Issuer Ratings, Recognitions, Positive Clinical Results, and Quarterly Dividends - Research Report on Pfizer, UnitedHealth, Merck, Gilead, and Bristol-Myers
8. Legal Actions, Quarterly Dividends, Collaborations, and New Appointments - Research Report on Johnson & Johnson, Zoetis, Abbott, Teva Pharmaceuticals, and Baxter
9. Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine
10. Successful Clinical Trials, Recognitions, Enrollment in Studies, Product Launches, and Strategic Announcements - Research Report on Boston Scientific, Gilead, Abbott, Actavis, and Covidien
11. New Research Finds Many Seniors Wrongly Think Public Health Insurance Exchanges Are Replacing Medicare Plans
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):